Exploratory Study of ZG-801 for the Treatment of Hyperkalemia
Status:
Completed
Trial end date:
2021-02-02
Target enrollment:
Participant gender:
Summary
To investigate the efficacy of each ZG-801 starting dose and the titration algorithm of
ZG-801 for the treatment of hyperkalemia in Japanese patients.
To evaluate the safety of ZG-801 for the chronic use (total over 52 weeks). In addition, to
confirm the safety after the discontinuation of ZG-801 treatment on 1 week follow-up.